The development of effective therapies for rare diseases remains a significant challenge, despite their impact on millions of people worldwide. A key barrier lies in translating promising academic discoveries into clinical applications. This session focuses on fostering collaboration across academia, industry, and clinical practice to drive patient-centered innovation.

The session will highlight the importance of translational research in bridging the gap between scientific discovery and clinical implementation. It will open with a keynote lecture showcasing how academic research on antisense oligonucleotide therapies for inherited blindness can be successfully advanced into clinical practice. This will be followed by three selected presentations featuring emerging research aligned with the session theme, offering insights into innovative approaches and future directions in rare disease therapy development.